To the Editor (Letter 2 of 2)

A J Kauppila; Antti Jaakko; Ilmari Kauppila

doi:10.1016/s0015-0282(97)90142-4

To the Editor (Letter 2 of 2)

A J Kauppila, Antti Jaakko, Ilmari Kauppila

Fertility and Sterility · 1997 · vol. 67(5) , pp. 975–976 · doi:10.1016/s0015-0282(97)90142-4 · PMID:9130915 · W2080139826

letter OA: bronze CC0

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Drug Costs Endometriosis Gonadotropin-Releasing Hormone Progestins Endometriosis Female Gonadotropin-Releasing Hormone Humans Pelvic Pain Pelvic Pain Progestins

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (4)

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex
W2343223033 via openalex
W2412454843 via openalex

Source provenance

europepmc: last seen: 2026-06-23T06:15:44.889181+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:10:52.568893+00:00

License: CC0 · commercial use OK

[1] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis 1987

[2] Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis 1996